MYO16 and lung cancer: Herein, we found that MYO16-AS1, a novel lncRNA expressed mainly in lung tissue, was downregulated in LUAD tissues and cell lines and that low expression of MYO16 is strongly associated with the severity and poor prognosis of lung cancer [17].